Patient experiences with continouous subcutaneous hydrocortisone infusion (CSHI)

Phillip Yeoh; Bernard Khoo; Paul Carroll; Simon Aylwin

doi:10.1530/endoabs.56.EP16

EP16

Prev Next

Section Contents Cite

Endocrine Abstracts (2018) 56 EP16 | DOI: 10.1530/endoabs.56.EP16

ECE2018 ePoster Presentations Adrenal and Neuroendocrine Tumours (28 abstracts)

Patient experiences with continouous subcutaneous hydrocortisone infusion (CSHI)

Phillip Yeoh , Bernard Khoo , Paul Carroll & Simon Aylwin

Views

Author affiliations

The London Clinic, London, UK.

We recently reported the impact of continous s.c. hydrocortisone infusion (CSHI) on weight, patient AddiQoL scores and healthcare cost savings on five patients. This poster is to follow up on all our patients experiences since started on the CSHI as well as qualitative feedback on the impact on their lives.

This poster also gathered key points on how these patients managed their adrenal crisis.